The Combination of GS-441524 (Remdesivir) and Ribavirin Results in a Potent Antiviral Effect Against Human Parainfluenza Virus 3 Infection in Human Airway Epithelial Cell Cultures and in a Mouse Infection Model
Human parainfluenza virus type 3 (HPIV-3) can cause severe respiratory diseases, particularly in young children, the elderly and immunocompromised. There are no approved antiviral drugs against this virus. We report that the combination of ribavirin with either remdesivir or its parent nucleoside GS...
Saved in:
| Main Authors: | Yuxia Lin, Birgit Weynand, Xin Zhang, Manon Laporte, Dirk Jochmans, Johan Neyts |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/2/172 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different?
by: Darius Babusis, et al.
Published: (2025-06-01) -
Simultaneous outbreaks of respiratory disease in wild chimpanzees caused by distinct viruses of human origin
by: Jacob D. Negrey, et al.
Published: (2019-01-01) -
Experimental Efficacy of an Alphavirus Vectored RNA Particle Vaccine Against Porcine Parainfluenza Virus-1 in Conventional Weaned Pigs
by: Michael Welch, et al.
Published: (2025-04-01) -
Efficacy of GS-441524 for Feline Infectious Peritonitis: A Systematic Review (2018–2024)
by: Emma Gokalsing, et al.
Published: (2025-07-01) -
Experimental Investigation of Ingavirin® Antiviral Activity Against Human Parainfluenza Virus
by: V. V. Zarubaev, et al.
Published: (2020-05-01)